Understanding DEA Regulations and FDA Interactions: A Case Study on Opioids

Lynn Mehler was a panel member during a session at the Food and Drug Law Institute (FDLI) Annual Conference: Exploring Advanced Topics in Food and Drug Law.

The panel for this session focused on how drug manufacturers, importers and exporters, pharmacies, and practitioners can balance Drug Enforcement Administration (DEA) and U.S. Food and Drug Administration (FDA) policies in order to remain compliant.

Learn More: Understanding DEA Regulations and FDA Interactions: A Case Study on Opioids


Back To Listing
Loading data